Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Keratosis, Actinic 22Carcinoma, Basal Cell 10Uterine Cervical Dysplasia 7Melanoma 7Breast Neoplasms 4Uterine Cervical Neoplasms 3Precancerous Conditions 3Keratosis 3Glioma 3Glioblastoma 3Condylomata Acuminata 3Urinary Bladder Neoplasms 2Squamous Intraepithelial Lesions 2Papillomavirus Infections 2Non-Muscle Invasive Bladder Neoplasms 2Neoplasm Metastasis 2Hutchinson's Melanotic Freckle 2HIV Infections 2Astrocytoma 2Warts 1Vulvar Neoplasms 1Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1Virus Diseases 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sialorrhea 1Sexually Transmitted Diseases 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Carboplatin 171Paclitaxel 129Radiotherapy 119Cisplatin 109Docetaxel 93Gemcitabine 81Erlotinib Hydrochloride 80Pemetrexed 78Bevacizumab 56Etoposide 41pembrolizumab 36Gefitinib 32Vinorelbine 31Topotecan 30Surveys and Questionnaires 29Irinotecan 28Radiosurgery 21Nivolumab 20Drug Therapy 20Magnetic Resonance Spectroscopy 18Cetuximab 18durvalumab 17Early Intervention, Educational 17Blood Specimen Collection 17Surgical Procedures, Operative 16Cyclophosphamide 16Celecoxib 15Ipilimumab 14Immunohistochemistry 14Filgrastim 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lung Neoplasms × Imiquimod × Clear all
NCT01909752 2017-07-06

Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer

UbiVac

Phase 2 Completed
12 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡